Jacobio Pharma Announces CNY486 Million Revenue for 2020 Annual Results

BEIJING and BOSTON, March 29, 2021 /PRNewswire/ — Jacobio Pharmaceuticals (1167.HK) announced its first annual results after its Hong Kong listing. By the end of December 31, 2020, its annual revenue was 486 million yuan and R&D expenses exceeded 230 million yuan and increased 66%…

Continue Reading

HEDGE accordingly